The hidden cost of chemotherapy: It could accelerate aging by up to 9 years in women with breast cancer

The research reveals that certain chemotherapy regimens for breast cancer can significantly accelerate patients’ biological aging, resulting in a shorter healthy life expectancy and a higher risk of mortality from other causes. Although this life-saving treatment improves oncological survival, it causes cumulative molecular damage that hastens the onset of age-related conditions, such as bone fragility and cognitive decline, thereby negatively affecting long-term quality of life. To counteract these adverse effects, experts emphasize the urgent need to adopt personalized care strategies and post-treatment rehabilitation. Promising interventions have been identified, including regular physical activity and the targeted use of specific medications, which can slow down this premature aging process. This approach aims to mitigate tissue damage and compensate for the loss of healthy life years, shifting the focus of survival toward a model that prioritizes comprehensive and sustained well-being. This study is relevant to the field of open data because it demonstrates the transformative power of population-based simulations grounded in established scientific data for modeling long-term effects. Methodological transparency and the use of research consortia that share predictive models enable a deeper understanding of the complex secondary consequences of medical treatments beyond immediate mortality. Promoting open access to these data and models facilitates informed clinical decision-making and future research on the overall impact of oncological therapies on aging.

Source: hoy.com.do
Published on 2026-11-11

The hidden cost of chemotherapy: It could accelerate aging by up to 9 years in women with breast cancer

Related news